<?xml version="1.0" encoding="UTF-8"?>
<p>When the UK went into lockdown on 24 March 2020, 70 patients were still receiving carfilzomib maintenance and 170 were on follow‐up (Fig 
 <xref rid="bjh17168-fig-0001" ref-type="fig">1</xref>). Adaptations to the trial protocol were agreed within the Trial Management Group (TMG), allowing CARDAMON to continue with minimal disruption. Local Principal Investigators (PIs) were informed of these changes, with open communication by email or telephone facilitating rapid resolution of further queries and efficient trial management throughout.
</p>
